Trial site
Klinikum rechts der Isar der TU München
München, 81675, GermanyNot linked to an institution yet
- 9running trials
- 5closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Phase
- Phase 25 trials
- Phase 35 trials
- Status
- Recruiting5 trials
- Active, not recruiting4 trials
- Completed4 trials
- Terminated1 trial
- Lead sponsor
- Goethe University3 trials
- Hoffmann-La Roche3 trials
- Eli Lilly and Company2 trials
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1 trial
- Janssen Research & Development, LLC1 trial
- and 4 more
Running trials
Recruiting
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
NCT07499232· Phase 3· Janssen Research & Development, LLC· Source
Recruiting
Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients
NCT07176312· Phase 2· Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest· Source
Contact: Alexander Stein, Prof. Dr.
Active, not recruiting
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
NCT06598943· Phase 2· Eli Lilly and Company· Source
Recruiting
A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)
NCT06780150· Hoffmann-La Roche· Source
Active, not recruiting
A Post-market Clinical Follow up of the Genio® System for the Treatment of Obstructive Sleep Apnea in Adults
NCT04031040· Nyxoah S.A.· Source
Active, not recruiting
A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy
NCT03839771· Phase 3· Stichting Hemato-Oncologie voor Volwassenen Nederland· Source
Active, not recruiting
A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer
NCT02246621· Phase 3· Eli Lilly and Company· Source
Recruiting
Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms - The Biology and Outcome (BiO)-Project
NCT01252485· University of Ulm· Source
Contact: Katharina Götze, Prof. Dr.
Recruiting
GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial
NCT02872987· Goethe University· Source
Contact: Nicola Gökbuget, Dr. med.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error